View in EDS HTML Full Text PDF Full Text

The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study.

Saved in:
Bibliographic Details
Title: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study.
Authors: Chen Y; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Luo J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Chen J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Kotlyar E; St. Vincent's Hospital, Sydney, NSW, Australia., Li Z; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Chen W; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Li J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 Jan 12; Vol. 12, pp. 811700. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35095523
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Luo+J%22">Luo J</searchLink>; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Kotlyar+E%22">Kotlyar E</searchLink>; St. Vincent's Hospital, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Jan 12; Vol. 12, pp. 811700. <i>Date of Electronic Publication: </i>2022 Jan 12 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35095523
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2021.811700
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 811700
    Titles:
      – TitleFull: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Luo J
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Kotlyar E
      – PersonEntity:
          Name:
            NameFull: Li Z
      – PersonEntity:
          Name:
            NameFull: Chen W
      – PersonEntity:
          Name:
            NameFull: Li J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 01
              Text: 2022 Jan 12
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1